Healthdirect Australia is not responsible for the content and advertising on the external website you are now entering.
Active ingredients: trimethoprim
What it is used for
This product approved for registration as a variation of a product accepted for inclusion in the ARTG as 'currently supplied' at the commencement of the Act. Indications are held in ARTG paper records. Previous Product Number AUST R 17577 and 43120. Product Information not reviewed. INDICATIONS AS AT 5 DECEMBER 1984 : Treatment of acute urinary tract infections caused by sensitive organisms.
How to take it
The way to take this medicine is: Oral. This medicine is taken by mouth.
- Store below 30 degrees Celsius
- Shelf lifetime is 3 Years.
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.
Always read the label. If symptoms persist see your healthcare professional.
9.5mm white normal convex tablet marked TM/300 on on side, G on reverse.
Images are the copyright of the Pharmacy Guild of Australia
Do I need a prescription?
This medicine is available from a pharmacist and requires a prescription. It is
Is this medicine subsidised?
This medicine was verified as being available on the PBS (Pharmaceutical Benefits Scheme) on June 1, 2021. To learn more about this subsidy, visit the Pharmaceutical Benefits Scheme (PBS) website.
Pregnant or planning a pregnancy?
For the active ingredient trimethoprim
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Consumer Medicines Information (CMI)
For side effects, taking other medicines and more
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems
Sulfonamide antibiotic allergy - Australasian Society of Clinical Immunology and Allergy (ASCIA)
Sulfonamide antibiotics can cause allergic reactions, ranging from mild rash to severe blistering rash through to anaphylaxis, the most dangerous type of allergic reaction.
Read more on ASCIA – Australasian Society of Clinical Immunology and Allergy website